We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$2.18B
AUM Growth
+$98.8M
Cap. Flow
-$48.3M
Cap. Flow %
-2.22%
Top 10 Hldgs %
23.55%
Holding
369
New
57
Increased
84
Reduced
142
Closed
66

Sector Composition

Rank Sector Weight
1 Financials 18.72%
2 Consumer Discretionary 15.96%
3 Industrials 14.6%
4 Real Estate 8.31%
5 Technology 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVV icon
226
Valvoline
VVV
$4.97B
$596K 0.03%
+27,817
New +$614K
XPO icon
227
XPO
XPO
$25B
$594K 0.03%
21,564
-5,870
-21% -$161K
DCPH
228
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$587K 0.03%
+9,437
New +$449K
SAFE
229
DELISTED
Safehold Inc.
SAFE
$587K 0.03%
+14,564
New +$534K
NEWT icon
230
NewtekOne
NEWT
$417M
$581K 0.03%
25,643
-3,422
-12% -$77.2K
MRVL icon
231
Marvell Technology
MRVL
$174B
$577K 0.03%
21,735
+4,752
+28% +$120K
ATRS
232
DELISTED
Antares Pharma, Inc.
ATRS
$576K 0.03%
+122,622
New +$502K
SGI
233
Somnigroup International
SGI
$15.1B
$569K 0.03%
26,160
-364
-1% -$7.61K
EW icon
234
Edwards Lifesciences
EW
$47.6B
$567K 0.03%
7,293
-1,368
-16% -$107K
SLAB icon
235
Silicon Laboratories
SLAB
$7.15B
$563K 0.03%
4,853
-12,423
-72% -$1.36M
COR
236
DELISTED
Coresite Realty Corporation
COR
$549K 0.03%
+4,894
New +$566K
CUB
237
DELISTED
Cubic Corporation
CUB
$543K 0.03%
8,542
-7,869
-48% -$532K
TROW icon
238
T. Rowe Price
TROW
$25B
$531K 0.02%
4,355
+896
+26% +$106K
ROCK icon
239
Gibraltar Industries
ROCK
$1.34B
$513K 0.02%
+10,165
New +$511K
DOCU
240
DocuSign
DOCU
$9.63B
$498K 0.02%
+6,721
New +$462K
VGSH icon
241
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$497K 0.02%
8,170
-2,056
-20% -$125K
VGIT icon
242
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
$495K 0.02%
7,511
-1,890
-20% -$125K
KMX icon
243
CarMax
KMX
$8.27B
$491K 0.02%
5,602
+113
+2% +$10.6K
DRNA
244
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$477K 0.02%
+21,651
New +$436K
XOP icon
245
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
$468K 0.02%
4,935
HWM icon
246
Howmet Aerospace
HWM
$116B
$467K 0.02%
19,800
-235
-1% -$5.25K
ITT icon
247
ITT
ITT
$17.5B
$465K 0.02%
6,297
-58
-0.9% -$3.85K
MO icon
248
Altria Group
MO
$122B
$453K 0.02%
9,086
INMD icon
249
InMode
INMD
$872M
$452K 0.02%
+23,054
New +$433K
MPWR icon
250
Monolithic Power Systems
MPWR
$65.5B
$450K 0.02%
2,525
+878
+53% +$140K

Similar funds

Advisory Research's Q4 2019 Portfolio in Review

As of Q4 2019, Advisory Research held 369 positions worth $2.18B, up 4.8% from $2.08B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Advisory Research's Q4 2019 filing shows 57 new, 84 increased, 142 reduced and 66 closed positions. Its largest new stake was Lamar Advertising Co: 439,022 shares worth $39.2M. The largest sale was Accenture, an estimated $32.3M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Advisory Research's largest Q4 2019 buy was Lamar Advertising Co: 439,022 shares worth $39.2M.
  • Advisory Research added most to Huntington Bancshares in Q4 2019, an estimated $31.6M increase.
  • Advisory Research's biggest Q4 2019 reduction was Accenture, cutting an estimated $32.3M.
  • Advisory Research fully exited Honeywell in Q4 2019, selling an estimated $25.6M.
  • Advisory Research's ten largest holdings make up 24% of its $2.18B portfolio in Q4 2019.
  • Advisory Research opened 57 new positions and closed 66 in Q4 2019.
  • Advisory Research's portfolio value rose 4.8% quarter-over-quarter to $2.18B.

Based on Advisory Research's 13F filing for Q4 2019, filed 11 Feb 2020.